We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

79 hedge funds and large institutions have $161M invested in VanEck Biotech ETF in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 25 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

425% more call options, than puts

Call options by funds: $6.2M | Put options by funds: $1.18M

88% more capital invested

Capital invested by funds: $85.6M → $161M (+$75.5M)

40% more first-time investments, than exits

New positions opened: 7 | Existing positions closed: 5

10.85% more ownership

Funds ownership: 15.56% → 26.4% (+11%)

1% more funds holding

Funds holding: 78 → 79 (+1)

4% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 25

Holders
79
Holders Change
+1
Holders Change %
+1.28%
% of All Funds
2.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
26
Reduced
25
Closed
5
Calls
$6.2M
Puts
$1.18M
Net Calls
+$5.01M
Net Calls Change
-$177K

Top Buyers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
+$68.1M
2
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors
Iowa
+$2.92M
3
SG Americas Securities
SG Americas Securities
New York
+$2.5M
4
Nomura Asset Management
Nomura Asset Management
Japan
+$1.06M
5
Jane Street
Jane Street
New York
+$900K

Top Sellers

Rank Fund Capital Flow
1
VF
Virtu Financial
New York
-$3.38M
2
ECM
Endurant Capital Management
California
-$1.16M
3
Truist Financial
Truist Financial
North Carolina
-$914K
4
Millennium Management
Millennium Management
New York
-$834K
5
VKH
Virtu KCG Holdings
New York
-$676K
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
26
Endurant Capital Management
California
$709K -$1.16M -10,150 -62%
MFS
27
MSI Financial Services
Massachusetts
$709K -$73.9K -648 -10%
GJIC
28
Gamble Jones Investment Counsel
California
$691K – – –
Bank of America
29
Bank of America
North Carolina
$680K -$170K -1,492 -20%
LTFS
30
Ladenburg Thalmann Financial Services
Florida
$679K -$259K -2,270 -28%
Stifel Financial
31
Stifel Financial
Missouri
$598K -$210K -1,841 -26%
RJA
32
Raymond James & Associates
Florida
$591K +$33.1K +290 +6%
IA
33
IFP Advisors
Florida
$553K -$285K -2,505 -34%
Wells Fargo
34
Wells Fargo
California
$530K -$113K -991 -18%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$518K +$171K +1,501 +50%
IAMOG
36
Investors Asset Management of Georgia
Georgia
$426K – – –
TRCT
37
Tower Research Capital (TRC)
New York
$425K +$189K +1,660 +82%
RJFSA
38
Raymond James Financial Services Advisors
Florida
$405K +$72.4K +635 +22%
ClearBridge Investments
39
ClearBridge Investments
New York
$383K +$379K +3,325 New
CG
40
Cutler Group
California
$374K -$171K -1,500 -32%
EDRH
41
Edmond de Rothschild Holding
Switzerland
$373K +$35.9K +315 +11%
SC
42
Scotia Capital
Ontario, Canada
$351K +$36.5K +320 +12%
First Manhattan
43
First Manhattan
New York
$345K – – –
BRWA
44
B. Riley Wealth Advisors
Florida
$337K +$31.3K +275 +10%
AB
45
Atlas Brown
Kentucky
$335K -$4.67K -41 -1%
PCMM
46
Private Capital Management (Minnesota)
Minnesota
$334K -$85.5K -750 -21%
FAAS
47
First Allied Advisory Services
California
$331K +$11.4K +100 +4%
TBA
48
Train Babcock Advisors
New York
$315K +$312K +2,735 New
PAG
49
Private Advisor Group
New Jersey
$302K +$69K +605 +30%
SBH
50
Segall Bryant & Hamill
Illinois
$294K – – –
1
2
3 4

BBH Hedge Fund Activity: Q3 2016 in Review

79 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q3 2016, worth a combined $161M — up 88% from $85.6M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new BBH positions and 5 closed out — a net gain of 2 holders — while 26 added to existing stakes and 25 trimmed.

The largest buyer was AllianceBernstein, opening a new position worth an estimated $68.1M. The largest seller was Virtu Financial, exiting entirely with an estimated $3.38M sold.

  • 79 institutional investors held VanEck Biotech ETF (BBH) as of Q3 2016, up from 78 in Q2 2016.
  • Funds reported $161M of VanEck Biotech ETF stock for Q3 2016, up 88% quarter-over-quarter.
  • 7 funds opened new VanEck Biotech ETF positions in Q3 2016 and 5 closed out, a net change of +2 holders.
  • The largest VanEck Biotech ETF buyer in Q3 2016 was AllianceBernstein, an estimated $68.1M added.
  • The largest VanEck Biotech ETF seller in Q3 2016 was Virtu Financial, an estimated $3.38M sold.

Based on aggregated 13F filings for Q3 2016.